CO15 | Longitudinal coagulation profiling of individuals undergoing gender-affirming hormone therapy: the hyper-gender study
Background and Aims: Transgender individuals appear to have an increased risk of thrombosis due to hypercoagulability associated with gender-affirming hormone therapy (GAHT). The aim of the study was to investigate the effects of GAHT on coagulation, metabolism, and erythropoiesis, and to explore t...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CO22 | Assessment of coagulation profiles in septic patients using viscoelastic coagulation monitoring and rotational thromboelastometry in an internal medicine setting
Published: (2025-08-01) -
Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy
by: Brendan J. Nolan, et al.
Published: (2025-05-01) -
CO20 | Coagulation alterations as prognostic indicators in septic patients
Published: (2025-08-01) -
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review
by: Matteo Lambertini, et al.
Published: (2024-07-01) -
Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals
by: Timur Liwinski, et al.
Published: (2024-09-01)